Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Efforts by companies like GlaxoSMithKline to meet cost concerns of governments by linking pricing to the effectiveness of the drugs or treatments. Pharmaceutical pricing an issue with governments.
Grouped Articles
Wall Street Journal 11.09.2006
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06.10.2008
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07.08.2008
Drug Makers Trim Prices for Health Overhaul
Wall Street Journal 06.22.2009
For Drug Makers, Concessions Have a Bright Side
Wall Street Journal 06.23.2009
New York Times 06.25.2009
More Cost Cuts Sought From Drug Industry
New York Times 07.23.2009
India Prepares EU Trade Complaint
Wall Street Journal 08.06.2009
Democrats Say No to Cost Cap for Drug Makers
New York Times 08.07.2009
Economist 08.27.2009
President Obama writes a new health reform prescription
Washington Post 12.16.2009
Large Price Jumps Reported for Small but Vital Drugs
New York Times 01.11.2010
An ObamaCare Drug Preview in Germany
Wall Street Journal 07.08.2011
Austerity in Europe Puts Pressure on Drug Companies
New York Times 02.23.2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03.06.2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03.06.2012
Cost of Brand-Name Prescription Medicines Soaring
New York Times 11.28.2012
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08.26.2016
Mylan Reacts to EpiPen Backlash
WSJ 08.26.2016
Opinion | Sticking it to Pharma—With Competition
WSJ 11.20.2018
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1